Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-13, Stock:NVS, The news for the past five days is as follows:
2018-11-06: NEWS1: Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript.NEWS2: Health Care Sector Update for 11/06/2018: XNCR,MOR,MYL,AVNS.NEWS3: Health Care Sector Update for 11/06/2018: XNCR,MOR,MYL,AVNS.NEWS4: What Lies in Store for Ligand (LGND) This Earnings Season?.NEWS5: What Lies in Store for Ligand (LGND) This Earnings Season?.NEWS6: Mylan (MYL) Earnings Beat, Revenues Miss Estimates in Q3.NEWS7: Mylan (MYL) Earnings Beat, Revenues Miss Estimates in Q3.NEWS8: What Lies in Store for Ligand (LGND) This Earnings Season?.NEWS9: Is A Disappointment in Store for Tilray (TLRY) Q3 Earnings?.NEWS10: Is A Disappointment in Store for Tilray (TLRY) Q3 Earnings?.
2018-11-07: NEWS1: This Rockville biotech is expanding to a new HQ. Here are the details..NEWS2: Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes.NEWS3: Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes.NEWS4: Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes.NEWS5: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 08, 2018.NEWS6: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 08, 2018.
2018-11-08: NEWS1: Ligand Pharmaceuticals Inc (LGND) Q3 2018 Earnings Conference Call Transcript.NEWS2: Mylan’s Major Drivers: Biosimilars and Asset Acquisitions.NEWS3: Here&apos;s Why PTC Therapeutics Dropped 18% in October.
2018-11-09: NEWS1: Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View.NEWS2: Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View.NEWS3: Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View.NEWS4: Novartis division Sandoz recalls one lot of blood pressure drug.
2018-11-12: NEWS1: These Biopharmas Could Cure Genetic Diseases — At $5 Million Apiece.

Answer: Rise